You need to enable JavaScript to run this app.
优惠活动
大模型
产品
解决方案
定价
更多

基于虚假回归因子的BSTS与Google Correlate时间序列的因果影响分析问询

分析基于虚假关联因子的BSTS因果分析中安慰剂处理的结果

Great question—let’s break this down step by step, since you’re dealing with a classic spurious correlation scenario in causal inference using Bayesian Structural Time Series (BSTS).

First, let’s recap your setup to make sure we’re aligned:

  • You’ve got a Google Correlate time series (let’s call it X) that’s highly correlated with your target y pre-intervention, but this is a spurious association (no causal link, driven by unobserved confounders or coincidental trends).
  • X is extremely unlikely to be affected by your actual intervention, so the true causal effect of the intervention on X is 0.
  • Your initial BSTS analysis using X as a regressor showed a significant, directionally expected effect on y—but this is almost certainly driven by the pre-existing spurious correlation, not a real causal relationship.

Now, what happens when you run a placebo test here? Here’s what you should expect:

  • Primary outcome: Placebo intervention effects will be near-zero and statistically insignificant
    Since X isn’t actually impacted by your intervention, simulating a "placebo intervention" (e.g., assigning a fake treatment time point to X, or treating X as the "treated" variable in a synthetic control-style placebo check) will not produce a meaningful effect on y. BSTS models account for time trends, seasonality, and autocorrelation, so it will attribute the pre-existing spurious correlation between X and y to these baseline time series components—not the fake intervention. The estimated causal effect from the placebo test will hover around 0, with credible intervals that include 0 (meaning no statistically significant effect).

  • Placebo tests will expose the spurious nature of your initial result
    Your initial significant effect is a false positive driven by the pre-intervention spurious correlation. When you run multiple placebo tests (e.g., shifting the fake intervention time to different pre-intervention windows, or using other spurious correlates as placebo regressors), you’ll see that "significant" effects are rare and random—they won’t consistently align with your expected direction. This is a key red flag that your initial result isn’t causal.

  • Edge case: Rare false positives from coincidental confounder trends
    In extremely rare cases, you might get a false positive placebo result if the unobserved confounder driving the X-y spurious correlation happens to have a trend shift that lines up exactly with your placebo intervention window. But this is a chance occurrence. If you repeat the placebo test across multiple random time windows, fewer than 5% of tests (assuming α=0.05) should show a "significant" effect—consistent with the expected Type I error rate.

The core takeaway here is that placebo tests are designed to catch exactly this kind of spurious correlation-driven false positive. Since your X variable has no real causal link to the intervention or y, the placebo check will fail to replicate your initial "significant" result, confirming that the original finding isn’t a true causal effect.

内容的提问来源于stack exchange,提问作者Juan Martínez

相关产品推荐
方舟 Agent Plan

超全模态模型 × Harness 升级,最新支持 Deepseek-V4.1-Flash、GLM-5.3 系列、Doubao-Seedream-5.0-pro、Kimi-K3 (部分), 限时 9.9 元起

最近更新时间:2026.05.19 09:06:49